Johnson & Johnson to Build $1+ Billion Cell Therapy Facility in Pennsylvania

MONTGOMERY COUNTY, Pa. — Johnson & Johnson announced a more than $1 billion investment in a next-generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. The project is expected to create more than 4,000 construction jobs and support over 500 permanent biomanufacturing positions once fully operational.

“For 140 years, Johnson & Johnson has been a leading innovator in American healthcare, and we are honored to continue advancing that legacy in Pennsylvania,” said Joaquin Duato, Chairman and Chief Executive Officer of Johnson & Johnson.